GL1X · GenesisL1 explorer

Research workbench

The crystal structure of inhibitor bound to jcv helicase

Analyse The crystal structure of inhibitor bound to jcv helicase in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5J4V
Type
protein
Length
358 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Large T antigen
EC
3.6.4.-
UniProt
P03072
Ligands
6JH, ZN, SO4
Pockets
3 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 59% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALarge T antigen (EC 3.6.4.-)protein35859% helix, 8% strandP03072

Ligands and binding sites

  • 6JH · 2-(2-phenoxypyridin-3-yl)[1,3]thiazolo[5,4-c]pyridine · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • SO4 · Sulfate ion · ion · chains A
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13880.650.7950empty
2930.520.8313empty
31230.460.7822SO4, 6JH

Compared structures

  • 5J4V · The crystal structure of Inhibitor Bound to JCV Helicase · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.